BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210424T080000
DTEND;TZID=America/Los_Angeles:20210424T123000
DTSTAMP:20260404T071009
CREATED:20210420T152404Z
LAST-MODIFIED:20210420T152404Z
UID:5306-1619251200-1619267400@carb-x.org
SUMMARY:9th Annual Cystic Fibrosis Symposium 2021
DESCRIPTION:This course is designed to increase the knowledge of managing patients with CF across the lifespan of all who interact with this population.\nAbout this Event \nThe target audience includes nurses\, respiratory therapists\, physical and occupational therapists\, social workers\, dieticians\, child life specialists\, and physicians \nClick here to learn more and register.
URL:https://carb-x.org/event/9th-annual-cystic-fibrosis-symposium-2021/
LOCATION:Auditorium at UCLA Medical Center\, Santa Monica\, 1250 16th Street\, Santa Monica\, CA\, 90404\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210427
DTEND;VALUE=DATE:20210429
DTSTAMP:20260404T071009
CREATED:20210420T152022Z
LAST-MODIFIED:20210420T152022Z
UID:5304-1619481600-1619654399@carb-x.org
SUMMARY:BactiVac Online: Virtual Network Conference 2021
DESCRIPTION:Delivering our 2021 Virtual Network Conference in an innovative online format will provide a unique opportunity to hear about the latest bacterial vaccinology research from leading international researchers in a safe environment. Talks will be delivered by a host of internationally renowned speakers from a range of disciplines\, all actively involved in the research area of bacterial vaccinology. Please view the programme for our virtual conference\, together with speaker profiles. \nThe conference is open and free to attend for BactiVac Network members only and booking is compulsory; you can apply for free membership here. Registration for the conference is now closed. \nKeep up to date by following us on @BactiVac\, using #BactiVacEvents. You can also download BactiVac Virtual Conference flyer to circulate and/or display within your organisation. \nFor any queries regarding virtual conference\, please contact us at: bactivac@contacts.bham.ac.uk \nClick here to learn more.
URL:https://carb-x.org/event/bactivac-online-virtual-network-conference-2021/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210429
DTEND;VALUE=DATE:20210501
DTSTAMP:20260404T071009
CREATED:20201207T215133Z
LAST-MODIFIED:20210127T224039Z
UID:4763-1619654400-1619827199@carb-x.org
SUMMARY:BSAC Spring Conference
DESCRIPTION:Additional details forthcoming. Click here to learn more. \n 
URL:https://carb-x.org/event/bsac-spring-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210429T110000
DTEND;TZID=America/New_York:20210429T123000
DTSTAMP:20260404T071009
CREATED:20210408T220314Z
LAST-MODIFIED:20210408T220314Z
UID:5256-1619694000-1619699400@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE – AMR R&D efforts in the CMC and formulation arena: Do it right the first time!
DESCRIPTION:Speaker: Aleksandar Danilovski\, Chief Scientific Officer\, Xellia Pharmaceuticals (Denmark) \nModerator: TBC \nAleksandar’s presentation will discuss: \n\nAre CMC and formulation efforts treated as the foster child in the innovation and development armament?\nUnderestimating CMC and formulation aspects can potentially cause significant delays and project failures\nAppropriate (what\, how and when) CMC and formulation innovation and development strategies can improve overall probability of project success\, can bring competitive advantages (including IP umbrella) and can reduce time to market – Do it right the first time!\n\nThe presentation will be followed by a Q&A session. \nClick here to learn more and register.
URL:https://carb-x.org/event/live-webinar-gardp-revive-amr-rd-efforts-in-the-cmc-and-formulation-arena-do-it-right-the-first-time/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210504
DTEND;VALUE=DATE:20210507
DTSTAMP:20260404T071009
CREATED:20201203T010043Z
LAST-MODIFIED:20210216T161720Z
UID:4697-1620086400-1620345599@carb-x.org
SUMMARY:World Vaccine Congress Washington 2021
DESCRIPTION:For the past 20 years\, the World Vaccine Congress Washington congress has evolved and grown into the leading vaccines congress globally\, with hundreds of speakers\, thousands of attendees and hundreds of networking opportunities. Our event format allows for whole-sector topics\, giving an opportunity for people to find out more about their specific area of research and their job-function. By running parallel niche conference channels over the 3 days\, it increases the relevance of the whole event for everyone who attends. \n\nCancer Immunotherapy\nImmune Profiling\nRespiratory Vaccines\nEmerging & Infectious Diseases\nClinical Trials\nVaccine Partnerships\nBioprocessing & Manufacturing\nVaccines Safety\nLogistics\nVeterinary Vaccines\nPartnerships\n\nDuring these sessions you will learn how cutting-edge research efforts can be integrated with pharma\, biotech\, academia and government to produce more and better vaccines to the market. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/world-vaccine-congress-washington-2021/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210512T110000
DTEND;TZID=America/New_York:20210512T123000
DTSTAMP:20260404T071009
CREATED:20210510T191153Z
LAST-MODIFIED:20210510T191338Z
UID:5336-1620817200-1620822600@carb-x.org
SUMMARY:Duke-Margolis Center for Health Policy Webinar: Combating Rising Antimicrobial Resistance (AMR) & Advancing Public Health Preparedness
DESCRIPTION:Join the Duke-Margolis Center for Health Policy—including an introduction by former FDA Commissioners Dr. Mark McClellan and Dr. Scott Gottlieb—for an important discussion on combating rising antimicrobial resistance (AMR) in the context of U.S. public health preparedness\, support for novel antibiotics\, global AMR policy leadership\, and emerging multi-sector innovation. \nRising antimicrobial resistance remains a top global public health threat and efforts to support novel antibiotic development and availability are more critical and timely than ever. As the ongoing pandemic centers national and global conversations around actions to prevent and combat future infectious disease threats\, the time to take action against AMR is now. \nCARB-X participants include Kevin Outterson\, Executive Director\, who will join the panel for Session 2: Global Policy Leadership and Proposals to Combat AMR at 11:25AM ET.  This session will highlight how the U.S. can lead policy approaches to combat AMR through existing legislative proposals and opportunities to coordinate domestic\nactions with existing international efforts.  \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/duke-margolis-center-for-health-policy-webinar-combating-rising-antimicrobial-resistance-amr-advancing-public-health-preparedness/
LOCATION:WEBINAR\, Webinar\, Webinar\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210620
DTEND;VALUE=DATE:20210626
DTSTAMP:20260404T071009
CREATED:20201203T011106Z
LAST-MODIFIED:20201203T011106Z
UID:4699-1624147200-1624665599@carb-x.org
SUMMARY:Gordon Research Conference: Structure\, Dynamics and Development of Bacterial Cells
DESCRIPTION:Bacterial cells are exquisitely organized in time and space\, and carry out complex decision-making\, intercellular coordination\, and development to thrive in diverse environments. The 2021 inaugural Bacterial Cell Biology and Development Gordon Research Conference will explore recent research into the organization\, dynamics\, and development of bacterial cells and communities using a breadth of experimental approaches and biological systems. Invited speakers will present work probing the fundamental cell biological mechanisms of growth and division\, and of the specialized behaviors and developmental pathways bacteria engage to ensure survival in changing environments. Inclusion of research in species that span bacterial phylogeny\, lifestyles\, and growth niches will stimulate thought and discussions on the conservation and evolution of cell biological mechanisms in bacteria. \nThe 2021 Bacterial Cell Biology and Development GRC brings together a group of international scientists including cell biologists\, bacteriologists\, biochemists\, geneticists\, physicists\, structural biologists\, and imaging specialists to facilitate a collaborative and interdisciplinary discussion of bacterial cell biology and development. The program will comprise talks from 24 invited speakers organized into 9 thematic sessions\, with an additional ~20 short talks selected from submitted abstracts. Daily poster sessions and ample free time will enable networking\, collaboration\, brainstorming\, and other informal interactions among attendees. As a new GRC\, we are not able to hold a trainee-oriented Gordon Research Seminar in conjunction with this inaugural meeting. Look for this offering in future iterations of this GRC. \nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/gordon-research-conference-structure-dynamics-and-development-of-bacterial-cells/
LOCATION:Colby-Sawyer College\, 541 Main Street\, New London\, NH\, 03257\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210620
DTEND;VALUE=DATE:20210625
DTSTAMP:20260404T071009
CREATED:20210127T224752Z
LAST-MODIFIED:20210607T161650Z
UID:4896-1624147200-1624579199@carb-x.org
SUMMARY:World Microbe Forum
DESCRIPTION:From new infectious pathogens like SARS-CoV-2\, to antimicrobial resistance and the role of microbes in climate change\, to agriculture and food microbiology\, and synthetic and applied microbiology – international experts will gather for World Microbe Forum to examine\, discuss and envision solutions that science can offer to solve some of the gravest concerns confronting us today. \nThis unique and special event\, a collaboration between the American Society for Microbiology (ASM) and the Federation of European Microbiological Societies (FEMS)\, is bringing together two of the biggest events in the microbial sciences\, ASM Microbe 2021 and FEMS2021\, to further science and help answer some of the most important questions impacting humankind. Additional scientific societies\, including the American Society for Virology (ASV) and the African Society for Laboratory Medicine (ASLM) will be key partners in this event. \nExplore the hottest topics in microbiology\, discussed like never before\, and offering unparalleled access to the latest innovative research across global perspectives. Create meaningful connections with peers from around the world. Be a part of this first-of-its-kind virtual meeting uniting the microbial sciences community.  \nCARB-X participants include Erin Duffy\, Chief of R&D\, who will join a panel focused on “Advancing Collaborations in the Global Fight Against AMR and Pandemics” on June 21st from 11am to 12:30pm ET. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/world-microbe-forum/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210622
DTEND;VALUE=DATE:20210624
DTSTAMP:20260404T071009
CREATED:20210316T151707Z
LAST-MODIFIED:20210316T151707Z
UID:5168-1624320000-1624492799@carb-x.org
SUMMARY:Sepsis Tech & Innovation 2021
DESCRIPTION:Following the success of the inaugural Sepsis Alliance Summit in 2020\, Sepsis Alliance is proud to announce the inaugural Sepsis Tech & Innovation virtual conference. Engage with the nation’s leading innovators\, clinicians\, investors\, and policymakers to discuss health technology and innovation\, and its tremendous potential to reduce the burden of sepsis. \nCatapulting off of Sepsis Alliance’s successful 2020 Sepsis Alliance Summit with more than 4\,000 registered attendees\, Sepsis Tech and Innovation is a very exciting opportunity for Sepsis Alliance to expand its voice in the health innovation and technology space. Our ultimate goal is to help take the costly guesswork out of sepsis diagnosis and care. In addition to education and training\, technology and innovation are critical to achieving major progress in reducing the burden of sepsis\, both in terms of lives lost and resources spent. Sepsis may be the best opportunity to leverage tech and innovation to save lives and reduce health spending in the nation. Sepsis Alliance is proud to offer Sepsis Tech & Innovation at no charge to participants. \nCARB-X participants include Erin Duffy\, Chief of Research and Development\, who will be leading the session “Therapeutics: Innovation and Challenges in the Fight Against AMR” on June 23\, 12:40pm – 1:10pm ET.   \nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/sepsis-tech-innovation-2021/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210624
DTEND;VALUE=DATE:20210625
DTSTAMP:20260404T071009
CREATED:20210216T143732Z
LAST-MODIFIED:20210216T143732Z
UID:5000-1624492800-1624579199@carb-x.org
SUMMARY:Promoting Innovative Antibiotic R&D in Switzerland
DESCRIPTION:The event “Promoting Innovative Antibiotic R&D in Switzerland” brings together protagonists of Antibiotic Research and Development from academic\, industrial\, political and funding organizations active in Switzerland. \nIts objective is discussing ways to facilitate technology transfer from academia to an industrial setting and to further the development of an attractive ecosystem\, at national and international level\, for bringing new antibiotics to the market. \nInitially planned for March 2020 and postponed due to COVID-19\, this gathering of the Antibiotic R&D community is all the more anticipated to give impulses to the field on 24th June 2021! \nJune 24th\, 2021 l Ort Hotel ODELYA\, Missionstr. 21\, CH-4055 Basel \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/promoting-innovative-antibiotic-rd-in-switzerland/
LOCATION:Ort Hotel ODELYA\, Missionstr. 21\, Basel\, CH-4055\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210626
DTEND;VALUE=DATE:20210628
DTSTAMP:20260404T071009
CREATED:20201203T012554Z
LAST-MODIFIED:20201203T012554Z
UID:4702-1624665600-1624838399@carb-x.org
SUMMARY:Gordon Research Conference: Antimicrobial Host Defense Peptides: Biological Functions\, Mechanisms of Action and Therapeutic Intervention
DESCRIPTION:The Gordon Research Seminar on Antimicrobial Peptides is a unique forum for graduate students\, post-docs\, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas. \nAntimicrobial Host Defense Peptides have been implicated in infection\, inflammation\, cancer and autoimmunity. As such\, the 2021 Gordon Research Seminar on Antimicrobial Peptides will focus on the biological function and mechanisms of action of these peptides in health and disease\, and how their properties can be exploited to provide therapeutic intervention. \nThis GRS will be held in conjunction with the “Antimicrobial Peptides” Gordon Research Conference (GRC). Those interested in attending both meetings must submit an application for the GRC in addition to an application for the GRS. Refer to the associated GRC program page for more information. \nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/gordon-research-conference-antimicrobial-host-defense-peptides-biological-functions-mechanisms-of-action-and-therapeutic-intervention/
LOCATION:Four Points Sheraton / Holiday Inn Express\, 1050 Schooner Drive\, Ventura\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210627
DTEND;VALUE=DATE:20210630
DTSTAMP:20260404T071009
CREATED:20201203T013118Z
LAST-MODIFIED:20210309T184902Z
UID:4703-1624752000-1625011199@carb-x.org
SUMMARY:8th International Human Microbiome Congress (IHMC 2020)
DESCRIPTION:In June 2021\, the 8th International Human Microbiome Consortium Meeting will include a fully digital format. By doing this we can ensure compliance of healthy and safety measures\, and we can guarantee participation from our delegates. \nWith the support of the IHMC board\, a strong local Organizing Committee and a Scientific Committee composed of the most renowned scientists and researchers in the Microbiota field\, the Congress expects to attract a large international audience of over 1\,000 delegates. \nThe program will include the latest scientific developments and a variety of activities of interest for early stage to senior researchers\, clinical professionals\, academia\, the industry as well as the general public. Commercial stands will be also featured for the duration of the congress to foster networking and commercial opportunities among companies and delegates attending the event. The event will be accredited to provide Credits for Continuing Medical Education (EACCME) and will be structured around plenary sessions in the morning and parallel sessions\, symposia and satellite events for companies in the afternoon. \nThe event will also include the 7th edition of the Barcelona Debates on the Human Microbiome\, from microbes to human\, a meeting where the most recent studies on the complex human-microbiome relationship and how the microbiome can influence in improving the clinical practices are discussed. \nThe day the Congress starts\, Saturday 27th of June\, coincides with the World Microbiome Day. To celebrate this day\, a variety of activities will be organized and will be open to the general public to broaden their awareness of the microbiome and their effects. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/8th-international-human-microbiome-congress-ihmc-2020/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210627
DTEND;VALUE=DATE:20210703
DTSTAMP:20260404T071009
CREATED:20201203T013414Z
LAST-MODIFIED:20201203T013414Z
UID:4693-1624752000-1625270399@carb-x.org
SUMMARY:Gordon Research Conference: Antimicrobial Peptides
DESCRIPTION:Additional details forthcoming. \nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/gordon-research-conference-antimicrobial-peptides/
LOCATION:Four Points Sheraton / Holiday Inn Express\, 1050 Schooner Drive\, Ventura\, CA\, 93001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210629
DTEND;VALUE=DATE:20210701
DTSTAMP:20260404T071009
CREATED:20210127T232452Z
LAST-MODIFIED:20210127T232452Z
UID:4904-1624924800-1625097599@carb-x.org
SUMMARY:ICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance
DESCRIPTION:The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality\, it provides an exceptional value for students\, academics and industry researchers. \nICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance aims to bring together leading academic scientists\, researchers and research scholars to exchange and share their experiences and research results on all aspects of Antibiotics and Antibiotic Resistance. It also provides a premier interdisciplinary platform for researchers\, practitioners and educators to present and discuss the most recent innovations\, trends\, and concerns as well as practical challenges encountered and solutions adopted in the fields of Antibiotics and Antibiotic Resistance \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/icaar-2021-15-international-conference-on-antibiotics-and-antibiotic-resistance/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210629
DTEND;VALUE=DATE:20210702
DTSTAMP:20260404T071009
CREATED:20210420T152648Z
LAST-MODIFIED:20210420T152648Z
UID:5305-1624924800-1625183999@carb-x.org
SUMMARY:6th Microbiome Movement - Drug Development Summit
DESCRIPTION:Welcome to the 6th Microbiome Movement – Drug Development Summit\, the most comprehensive forum for microbiome drug developers\, the Microbiome Movement! \nContinuing to unite the most forward thinking and industry researchers from the biopharmaceutical industry\, our unrivaled program will uncover microbiome functionality and mechanisms\, advance clinical development\, overcome the key CMC challenges\, whilst also discovering and applying microbiome biomarkers for improved clinical outcomes. This is THE must attend conference for microbiome drug developers. \nRecent clinical successes within the space are paving a way for the first FDA approved microbiome therapeutic\, however\, there still remains a number of unique scientific and practical challenges that must be overcome to pursue the causal role of the microbiome in disease\, and translate the complex science into realized and effective therapies that improve patient outcomes. \nOur end-to-end discussion will unite 65+ expert speakers and 250+ key decision-makers to provide you with valuable insights into the latest scientific discoveries and industry progress\, to help overcome the obstacles holding back therapeutic approval. This summit provides unique a platform for lasting connections with leaders at the cutting edge of making microbiome therapeutics an effective reality. \nThe 6th Microbiome Movement – Drug Development Summit is the perfect opportunity for the industry to take a collaborative approach to close the clinical gap\, discover the next generation of microbiome-based therapeutics\, and establish new partnerships to accelerate your research.  \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/6th-microbiome-movement-drug-development-summit/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210629
DTEND;VALUE=DATE:20210701
DTSTAMP:20260404T071009
CREATED:20210623T180031Z
LAST-MODIFIED:20210623T180135Z
UID:5483-1624924800-1625097599@carb-x.org
SUMMARY:Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) Virtual Public Meeting
DESCRIPTION:The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) provides advice\, information\, and recommendations to the Secretary regarding programs and policies intended to support and evaluate the implementation of U.S. government activities related to combating antibiotic-resistant bacteria.\n\n\n\n\n\n\nAt the June 29-30\, 2021 Virtual Public Meeting\, the PACCARB will deliberate and vote on two reports to transmit to the Secretary of Health and Human Services\, the first from the Disparities in Antibiotics Access and Use Working Group\, and the second from the Working Group on Antimicrobial Resistance (AMR) in Inter-Professional Education. The remainder of the 2-day public meeting will include an update on the status of the antibiotic development pipeline and an open council discussion on provocative questions in AMR (no recommendations will be made)\, in addition to presentations on Operationalizing One Health and the Environmental Dimensions of AMR. \nDate and Time:\nJune 29\, 2021 | 10:00 a.m. – 3:00 p.m. ET\nJune 30\, 2021 | 10:00 a.m. – 3:00 p.m. ET \n\n\n\n\n\nCARB-X participants include Kevin Outterson\, Executive Director\, who will be leading a session titled “THE ANTIBIOTICS PIPELINE: PAST\, PRESENT\, AND FUTURE” on June 29th at 12.05pm ET. \nClick here to learn more. \nClick here to view the agenda.\nClick here to view a live stream of the event.
URL:https://carb-x.org/event/presidential-advisory-council-on-combating-antibiotic-resistant-bacteria-paccarb-virtual-public-meeting/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210705T080000
DTEND;TZID=America/New_York:20210705T120000
DTSTAMP:20260404T071009
CREATED:20210623T175205Z
LAST-MODIFIED:20210623T175205Z
UID:5481-1625472000-1625486400@carb-x.org
SUMMARY:Advances in Antimicrobial Innovation Scientific meeting
DESCRIPTION:This Royal Society conference will bring together scientists\, medical practitioners and funding bodies to raise awareness and interest for new anti-microbial advances. \nAnti-microbial resistance continues to grow as a worldwide health challenge. Pathogens are continually evolving to combat drugs given to treat potentially life-threatening diseases\, rendering treatments ineffective and threatening the many advances in fighting microbes over recent decades. \nAs therapeutics in current use become less effective\, new approaches are required. This event aims to raise awareness and interest for new anti-microbial advances\, the challenges faced in market delivery\, and their appropriate use in healthcare systems. \nAbout the conference series:\nThe conference is part of the Royal Society’s Transforming our future conferences in the life sciences\, supported by AstraZeneca. These meetings are unique\, high-level events that address the scientific and technical challenges of the next decade. Each conference features cutting edge science from industry and academia and brings together leading experts from the scientific community\, including regulatory\, charity and funding bodies. This conference also forms part of the Academy of Medical Sciences’ FORUM programme. \nCARB-X participants include Erin Duffy\, Chief of R&D\, who will participate in the session ‘Challenges of prescribing\, diagnostics and antibiotic education\, investment and building a business model for new antibiotics’ between 3.30pm – 4.30pm EST. \nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/advances-in-antimicrobial-innovation-scientific-meeting/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210709
DTEND;VALUE=DATE:20210713
DTSTAMP:20260404T071009
CREATED:20200908T161215Z
LAST-MODIFIED:20210309T184944Z
UID:4330-1625788800-1626134399@carb-x.org
SUMMARY:31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
DESCRIPTION:We invite you to the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)\, which will take place in Vienna\, Austria and virtually from 9 – 12 July 2021. This is the first time the event will take place in summer. ECCMID\, the world’s premier Clinical Microbiology & Infectious Diseases event\, brings together experts from relevant fields to present the latest findings and developments and share their expertise. The congress will take place in the beautiful city of Vienna at the Reed Messe Conference Centre\, as well as online\, allowing us to create a unique experience to all delegates regardless of the mode of participation. The programme committee has developed a multi-faceted programme to incorporate all of the exciting educational\, social and professional events that ECCMID has to offer. \nTo learn more\, click here.\nTo view the program\, click here.\nTo register\, click here.
URL:https://carb-x.org/event/31st-european-congress-of-clinical-microbiology-infectious-diseases-eccmid/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20210720T163000
DTEND;TZID=Europe/London:20210720T180000
DTSTAMP:20260404T071009
CREATED:20210623T174658Z
LAST-MODIFIED:20210623T174741Z
UID:5478-1626798600-1626804000@carb-x.org
SUMMARY:BSAC and LP Webinar: Diagnostic driven strategies for antimicrobial resistance in the UK
DESCRIPTION:BSAC Infection Clinical Dilema Series\nWebinar: Diagnostic driven strategies for antimicrobial resistance in the UK\n\nLongitude Prize is partnering with British Society for Antimicrobial Chemotherapy (BSAC) for the Infection Clinical Dilemmas webinar series. It will bring diagnostic developers together with clinicians and professional bodies working on diagnostic evaluation in and for the National Health Service (NHS) in the UK\, to build an understanding of the NHS commissioning path for AMR diagnostic tests. The event will include presentations by the Head of AMR at NHS England and National Institute for Health and Care Excellence (NICE)\, followed by an interactive ‘Ask an Expert’ session – with experts from Medicines and Healthcare products Regulatory Agency (MHRA)\, University of Oxford NIHR Community Healthcare MedTech and IVD Cooperative and clinicians – for developers to express challenges they face and ask questions about marketing access in the UK.\n\n\nThe webinar will take place on Tuesday 20th July\, 1630-1800hrs BST \nClick here to sign-up and register.
URL:https://carb-x.org/event/bsac-and-lp-webinar-diagnostic-driven-strategies-for-antimicrobial-resistance-in-the-uk/
LOCATION:WEBINAR\, Webinar\, Webinar\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210722T110000
DTEND;TZID=America/New_York:20210722T130000
DTSTAMP:20260404T071009
CREATED:20210720T161444Z
LAST-MODIFIED:20210720T161836Z
UID:5529-1626951600-1626958800@carb-x.org
SUMMARY:Innovations for Tackling Tuberculosis in the Time of COVID-19: A Two-Part Virtual Workshop
DESCRIPTION:Register now: Innovations for Tackling Tuberculosis in the Time of COVID-19: Part One of a Two-Part Workshop (July 22\, 11 AM – 1 PM ET) \nThis public workshop is the first in a two-part series that examines the innovations needed to meet the targets for ending tuberculosis (TB) set by the WHO End TB Strategy for 2030 and affirmed by the United Nations High-Level Meeting on the Fight Against Tuberculosis. The workshop will feature presentations and discussions that will consider emerging technologies in diagnostic testing and vaccine development\, improvements in TB treatment\, and how to ensure increased and sustained commitments to reach the goal of ending TB in high burden countries despite the challenges from COVID-19. \nThis first session will provide an update on the current status\, unmet needs\, and promising advances in diagnostics\, vaccines and therapeutics\, and the critical need for new business models in sustainably combating TB. \nCARB-X participants include Kevin Outterson\, Executive Director\, who will be a speaker during the workshop.  \n\n\n\nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/innovations-for-tackling-tuberculosis-in-the-time-of-covid-19-a-two-part-virtual-workshop/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210815
DTEND;VALUE=DATE:20210821
DTSTAMP:20260404T071009
CREATED:20210128T004926Z
LAST-MODIFIED:20210128T004926Z
UID:4923-1628985600-1629503999@carb-x.org
SUMMARY:Gordon Research Conference: Staphylococcal Diseases
DESCRIPTION:The description for this conference is being developed by the conference chairs. Please check back regularly for updates to this information. \nClick here to learn more.
URL:https://carb-x.org/event/gordon-research-conference-staphylococcal-diseases/
LOCATION:Grand Summit Hotel at Sunday River\, 97 Summit Road\, Newry\, ME\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210817T080000
DTEND;TZID=America/New_York:20210821T170000
DTSTAMP:20260404T071009
CREATED:20210309T185853Z
LAST-MODIFIED:20210309T185853Z
UID:5124-1629187200-1629565200@carb-x.org
SUMMARY:The World Economic Forum Special Annual Meeting - 2021 Singapore
DESCRIPTION:The World Economic Forum Special Annual Meeting 2021 in Singapore will convene on 17-20 August. The meeting follows the success of the Forum’s virtual Davos Agenda in January\, which brought together world leaders from government\, business and society. \n\n\nThe Special Annual Meeting 2021 was scheduled for 25-28 May. Although the World Economic Forum and Government of Singapore remain confident of the measures in place to ensure a safe and effective meeting\, and local transmission of COVID-19 in Singapore remains at negligible levels\, the change to the meeting’s timing reflects the international challenges in containing the pandemic. Current global travel restrictions have made planning difficult for an in-person meeting in the first half of the year. Furthermore\, differing quarantine and air transport regulations have increased the lead time necessary to ensure that participants globally can make arrangements to join. \n\n\nThe Special Annual Meeting 2021 in Singapore in August will be the first global leadership summit to address the challenges of recovering from the pandemic and laying the basis for a more inclusive and sustainable world. It will bring leaders face-to-face to focus on shaping solutions to the most pressing challenges of our times. \n\n\n“A global leadership summit needs the participation of all global stakeholders\,” said Klaus Schwab\, Founder and Executive Chairman of the World Economic Forum. “The Special Annual Meeting in Singapore in August will provide the place for leaders from business\, government and civil society to come together to address the steps for global recovery.”  \n\n\nClick here to learn more.
URL:https://carb-x.org/event/the-world-economic-forum-special-annual-meeting-2021-singapore/
LOCATION:Singapore
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210824T080000
DTEND;TZID=America/New_York:20210826T170000
DTSTAMP:20260404T071009
CREATED:20210824T161737Z
LAST-MODIFIED:20210824T161737Z
UID:5563-1629792000-1629997200@carb-x.org
SUMMARY:BIOCOM 5th AMR Conference 2021 ­– Summer Edition: AMR Briefing Sessions
DESCRIPTION:The #AMRconference is a platform for SMEs\, start-ups\, big pharma\, academia\, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market. \nThe “AMR Conference” was started in 2017 as part of the annual “Berlin Conference on Life Sciences” series which was established by BIOCOM AG twelve years ago as an event format to discuss the challenges of SME-driven innovation for the health market and to offer a platform for meeting experts from business\, science\, clinics\, finance\, regulatory affairs and intellectual property. \nEach day will offer an AMR briefing session in the afternoon (starting at 2pm CET) on a dedicated topic\, including live speakers\, high-level panel discussions\, and interactive exchange with the audience: \n\nDay 1 – Status quo & COVID-19 Impact: What has changed after one year of COVID?\nDay 2 – Financing & Investing: What’s new with funds\, incubators and accelerators?\nDay 3 – Policy & Incentives: What can we learn from best practices to go ahead?\n\nCARB-X participants include Erin Duffy\, Chief of R&D\, who is a speaker on the session “Focus on incubators and public-private accelerators in US and Europe – How they drive the AMR innovation pipeline” on Wednesday\, August 25th at 3:00 p.m. – 4:15 p.m. CEST\, and Kevin Outterson\, Executive Director\, who is a speaker on the session “What can we expect and learn from the US and UK pull incentive initiatives?” on Thursday\, August 26th at 02:00 p.m. – 03:15 p.m. CEST \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/biocom-5th-amr-conference-2021-summer-edition-amr-briefing-sessions/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210826
DTEND;VALUE=DATE:20210829
DTSTAMP:20260404T071009
CREATED:20210128T005413Z
LAST-MODIFIED:20210128T005413Z
UID:4925-1629936000-1630195199@carb-x.org
SUMMARY:Global Conference on Vaccines Research and Development
DESCRIPTION:The conference aims to empower future generations in different fields of Vaccinology to explore exciting research outcomes that lie in tune with the objectives and theme of this exciting event. It further helps you enhance your understanding of commercial\, scientific and regulatory issues that affect strategic decision making in the Vaccine Sector. \nThis global conference sets the stage for brain-storming discussions among the participants with its enriching Q&A sessions\, round table discussions and technical workshops and provides know-how of the latest methodologies and technicalities of Vaccines. Inspiring and educating talks from eminent scientists together with keynote lectures\, plenary sessions\, and video and poster presentations that span across the length and breadth of this conference. \nWe look forward to seeing you at Vaccines Conference-2021 in Paris\, France. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/global-conference-on-vaccines-research-and-development/
LOCATION:Paris\, France
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210830
DTEND;VALUE=DATE:20210902
DTSTAMP:20260404T071009
CREATED:20210714T144516Z
LAST-MODIFIED:20210714T144516Z
UID:5523-1630281600-1630540799@carb-x.org
SUMMARY:Public Workshop: Science and Regulation of Bacteriophage Therapy
DESCRIPTION:The Food and Drug Administration (FDA)\, Center for Biologics Evaluation and Research\, and the National Institutes of Health\, National Institute of Allergy and Infectious Diseases are announcing a public workshop entitled “Science and Regulation of Bacteriophage Therapy.” The purpose of the public workshop is to exchange information with the medical and scientific community about the regulatory and scientific issues associated with bacteriophage therapy. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/public-workshop-science-and-regulation-of-bacteriophage-therapy/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210831
DTEND;VALUE=DATE:20210904
DTSTAMP:20260404T071009
CREATED:20210128T005746Z
LAST-MODIFIED:20210128T005746Z
UID:4926-1630368000-1630713599@carb-x.org
SUMMARY:American Academy of Orthopaedic Surgeons (AAOS) 2021 Annual Meeting
DESCRIPTION:Click here to learn more.\nClick here to register.
URL:https://carb-x.org/event/american-academy-of-orthopaedic-surgeons-aaos-2021-annual-meeting/
LOCATION:San Diego\, California
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210915T100000
DTEND;TZID=America/New_York:20210915T110000
DTSTAMP:20260404T071009
CREATED:20210903T133040Z
LAST-MODIFIED:20210903T133040Z
UID:5579-1631700000-1631703600@carb-x.org
SUMMARY:BLUE KNIGHT™ Webinar: Antimicrobial Resistance – Breakthrough Innovation and  Breaking Barriers
DESCRIPTION:As multi-drug resistant bacteria become increasingly threatening to global public health and existing antibiotics are becoming ineffective\, the global community of public and private organizations and life science innovators are rallying around the Antimicrobial Resistance challenge. \nJohnson & Johnson Innovation has invited leading experts in the field to share their views. Why aren’t (enough) new antibiotics being developed to address the AMR challenge? What other innovations might help without increasing antibiotic resistance? \nJoin the discussion as thought leaders share their views on the challenges surrounding this global health threat and the potential solutions. \nTopics will include: \n\nPriority MDR bacterial pathogens of interest\nPotential interventions to prevent and treat MDR bacterial infections\nBarriers in the development and commercialization pathway\nThe need for policy change to address these barriers\nThe potential roles of various organizations and public-private partnerships\n\n*This program is part of BLUE KNIGHT™\, a collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA). \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/blue-knight-webinar-antimicrobial-resistance-breakthrough-innovation-and-breaking-barriers/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210921
DTEND;VALUE=DATE:20210925
DTSTAMP:20260404T071009
CREATED:20201203T014533Z
LAST-MODIFIED:20201203T014533Z
UID:4718-1632182400-1632527999@carb-x.org
SUMMARY:2021 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
DESCRIPTION:The ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance\, scheduled to take place on Sept. 1-4\, 2020 in Dublin\, Ireland\, has been cancelled due to the COVID-19 pandemic. Visit the ESCMID website for more details. The 2021 conference will take place on Sept. 21-24 in Boston\, Mass. \nCo-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID)\, this multidisciplinary meeting will address the challenges\, opportunities and current requirements for antimicrobial drug development for AMR. \nAdditional details forthcoming. \nClick here to learn more\, additional details forthcoming. 
URL:https://carb-x.org/event/2021-asm-escmid-joint-conference-on-drug-development-to-meet-the-challenge-of-antimicrobial-resistance/
LOCATION:Boston\, Venue Forthcoming\, Boston\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210927
DTEND;VALUE=DATE:20211003
DTSTAMP:20260404T071009
CREATED:20210128T005224Z
LAST-MODIFIED:20210128T005224Z
UID:4924-1632700800-1633219199@carb-x.org
SUMMARY:18th International Conference on Pseudomonas
DESCRIPTION:The scientific sessions include Genomics and gene regulation; Antimicrobial tolerance; Host-Pathogen interactions; Metabolism and Physiology; Harnessing the Potential of Pseudomonas species; Evolution and Coevolution; Ecology; and Multi-species Interactions. \nPlenary Speaker: Fiona Brinkman\, Canada\, Fellow of the Royal Society of Canada \nKeynote Speakers: Joseph Bondy-Denomy\, Paul Turner\, Barbara Kazmierczak\, Gregg Beckham\, Wei Huang\, Jenna Gallie\, Britt Koskella\, and Jessica Scoffield \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/18th-international-conference-on-pseudomonas/
LOCATION:Atlanta\, Georgia
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210928
DTEND;VALUE=DATE:20211001
DTSTAMP:20260404T071009
CREATED:20210805T182720Z
LAST-MODIFIED:20210805T182720Z
UID:5547-1632787200-1633046399@carb-x.org
SUMMARY:The Vaccines Against Shigella and ETEC (VASE) Conference
DESCRIPTION:This is an international gathering dedicated to developing Shigella and enterotoxigenic Escherichia coli (ETEC) vaccines\, hosted by PATH\, a global nonprofit dedicated to achieving health equity. \nRegistration is now open for the VASE Virtual Symposium\, which will be held online on 28 and 30 September 2021. Check out the full agenda and read the presentation abstracts. This fully virtual event will provide key updates on vaccines being developed for Shigella\, (ETEC) and other emerging diarrheal pathogens\, such as non-typhoidal Salmonella. \nClick here to learn more.
URL:https://carb-x.org/event/the-vaccines-against-shigella-and-etec-vase-conference/
LOCATION:VIRTUAL EVENT
END:VEVENT
END:VCALENDAR